Tocqueville Asset Management L.P. cut its position in Agilent Technologies, Inc. (NYSE:A) by 3.1% during the second quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The fund owned 328,089 shares of the medical research company’s stock after selling 10,375 shares during the period. Tocqueville Asset Management L.P. owned 0.10% of Agilent Technologies worth $19,459,000 as of its most recent filing with the SEC.

Several other hedge funds also recently modified their holdings of the company. Shell Asset Management Co. boosted its position in Agilent Technologies by 20.4% in the first quarter. Shell Asset Management Co. now owns 60,747 shares of the medical research company’s stock worth $3,212,000 after buying an additional 10,299 shares in the last quarter. Glen Harbor Capital Management LLC boosted its position in Agilent Technologies by 6.7% in the first quarter. Glen Harbor Capital Management LLC now owns 15,232 shares of the medical research company’s stock worth $805,000 after buying an additional 952 shares in the last quarter. Acadian Asset Management LLC boosted its position in Agilent Technologies by 4,588.8% in the first quarter. Acadian Asset Management LLC now owns 83,414 shares of the medical research company’s stock worth $4,410,000 after buying an additional 81,635 shares in the last quarter. Korea Investment CORP boosted its position in Agilent Technologies by 8.7% in the first quarter. Korea Investment CORP now owns 224,148 shares of the medical research company’s stock worth $11,851,000 after buying an additional 17,864 shares in the last quarter. Finally, Advisors Capital Management LLC acquired a new position in Agilent Technologies during the first quarter worth $757,000.

Agilent Technologies, Inc. (A) opened at 61.74 on Tuesday. The stock has a market cap of $19.88 billion, a PE ratio of 31.84 and a beta of 1.30. Agilent Technologies, Inc. has a 52 week low of $42.92 and a 52 week high of $62.42. The stock has a 50 day moving average price of $60.37 and a 200 day moving average price of $56.33.

Agilent Technologies (NYSE:A) last released its quarterly earnings data on Tuesday, August 15th. The medical research company reported $0.59 earnings per share for the quarter, topping the consensus estimate of $0.52 by $0.07. The business had revenue of $1.11 billion during the quarter, compared to analyst estimates of $1.09 billion. Agilent Technologies had a return on equity of 16.95% and a net margin of 14.36%. The company’s revenue was up 6.7% compared to the same quarter last year. During the same period last year, the company posted $0.49 EPS. On average, equities analysts predict that Agilent Technologies, Inc. will post $2.31 earnings per share for the current year.

TRADEMARK VIOLATION NOTICE: “Tocqueville Asset Management L.P. Sells 10,375 Shares of Agilent Technologies, Inc. (A)” was originally reported by TheOlympiaReport and is owned by of TheOlympiaReport. If you are accessing this story on another site, it was illegally stolen and reposted in violation of international copyright legislation. The legal version of this story can be viewed at https://theolympiareport.com/2017/08/22/tocqueville-asset-management-l-p-sells-10375-shares-of-agilent-technologies-inc-a.html.

A number of research firms have recently weighed in on A. Wells Fargo & Company upgraded Agilent Technologies from a “market perform” rating to an “outperform” rating and increased their price target for the stock from $42.92 to $60.73 in a report on Wednesday, July 12th. BidaskClub upgraded Agilent Technologies from a “buy” rating to a “strong-buy” rating in a report on Tuesday, July 11th. Deutsche Bank AG set a $68.00 price target on Agilent Technologies and gave the stock a “buy” rating in a report on Wednesday, August 16th. Robert W. Baird increased their price target on Agilent Technologies from $57.00 to $62.00 and gave the stock an “outperform” rating in a report on Wednesday, May 24th. Finally, J P Morgan Chase & Co reiterated an “overweight” rating and set a $70.00 price target on shares of Agilent Technologies in a report on Wednesday, August 16th. Three investment analysts have rated the stock with a hold rating and thirteen have assigned a buy rating to the company’s stock. The stock has an average rating of “Buy” and a consensus price target of $63.18.

In other news, insider Patrick Kaltenbach sold 2,074 shares of the firm’s stock in a transaction on Wednesday, May 31st. The stock was sold at an average price of $60.43, for a total value of $125,331.82. Following the completion of the sale, the insider now owns 42,212 shares of the company’s stock, valued at $2,550,871.16. The sale was disclosed in a legal filing with the SEC, which is accessible through this link. Also, insider Mark Doak sold 21,851 shares of the firm’s stock in a transaction on Tuesday, May 30th. The stock was sold at an average price of $60.00, for a total value of $1,311,060.00. The disclosure for this sale can be found here. Over the last three months, insiders have sold 88,036 shares of company stock valued at $5,315,704.

Agilent Technologies Company Profile

Agilent Technologies, Inc provides application focused solutions that include instruments, software, services and consumables for the entire laboratory workflow. The Company serves the life sciences, diagnostics and applied chemical markets. It has three business segments: life sciences and applied markets business, diagnostics and genomics business, and Agilent CrossLab business.

Institutional Ownership by Quarter for Agilent Technologies (NYSE:A)

Receive News & Ratings for Agilent Technologies Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Agilent Technologies Inc. and related companies with Analyst Ratings Network's FREE daily email newsletter.